KIF22 and central nervous system cancer: KIFs members (KIF1A, KIF1B, KIF2A, KIF3C, KIF4A, KIF9, KIF13A, KIF13B, KIF14, KIF15, KIF18A, KIF20A, KIF22, KIF23, KIF15, KIF18A, KIF20A, KIF22, KIF23, KIF26A) are highly expressed in glioma tissues (Wang et al., 2013; Chen et al., 2016; Sun et al., 2016; Zhang et al., 2016, 2022; Saito et al., 2017; Cho et al., 2019; Gao et al., 2020b; Iegiani et al., 2021; Ren et al., 2022; Tao et al., 2022; Pan et al., 2023), and are more expressed in glioma tissues with high malignant degree (Zhang et al., 2016).